Rankings
▼
Calendar
OCGN Q2 2024 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$578M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
+135.3% YoY
Gross Profit
$1M
100.0% margin
Operating Income
-$15M
-1354.0% margin
Net Income
-$15M
-1339.2% margin
EPS (Diluted)
$-0.04
QoQ Revenue Growth
+12.5%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$41M
Total Liabilities
$24M
Stockholders' Equity
$17M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$485,000
+135.3%
Gross Profit
$1M
-$14M
+108.1%
Operating Income
-$15M
-$24M
+34.4%
Net Income
-$15M
-$23M
+33.8%
← FY 2024
All Quarters
Q3 2024 →